Global PET Radiopharmaceuticals Market Insight and Forecast to 2026
The research team projects that the PET Radiopharmaceuticals market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Cardinal Health Inc. (U.S.)
Nordion, Inc. (Canada)
Lantheus Medical Imaging, Inc. (U.S.)
Mallinckrodt plc (Ireland)
Eczacibasi-Monrol Nuclear Products (Turkey)
GE Healthcare (U.K.)
IBA Molecular Imaging (Belgium)
Bracco Imaging S.p.A (Italy)
Bayer AG (Germany)
Advanced Accelerator Applications S.A. (France)
By Type
F-18
Ru-82
Others
By Application
Oncology
Cardiology
Neurology
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of PET Radiopharmaceuticals 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the PET Radiopharmaceuticals Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the PET Radiopharmaceuticals Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the PET Radiopharmaceuticals market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Cardinal Health Inc. (U.S.)
Nordion, Inc. (Canada)
Lantheus Medical Imaging, Inc. (U.S.)
Mallinckrodt plc (Ireland)
Eczacibasi-Monrol Nuclear Products (Turkey)
GE Healthcare (U.K.)
IBA Molecular Imaging (Belgium)
Bracco Imaging S.p.A (Italy)
Bayer AG (Germany)
Advanced Accelerator Applications S.A. (France)
By Type
F-18
Ru-82
Others
By Application
Oncology
Cardiology
Neurology
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of PET Radiopharmaceuticals 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the PET Radiopharmaceuticals Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the PET Radiopharmaceuticals Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the PET Radiopharmaceuticals market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by PET Radiopharmaceuticals Revenue
1.4 Market Analysis by Type
1.4.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 F-18
1.4.3 Ru-82
1.4.4 Others
1.5 Market by Application
1.5.1 Global PET Radiopharmaceuticals Market Share by Application: 2021-2026
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Neurology
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global PET Radiopharmaceuticals Market Perspective (2021-2026)
2.2 PET Radiopharmaceuticals Growth Trends by Regions
2.2.1 PET Radiopharmaceuticals Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 PET Radiopharmaceuticals Historic Market Size by Regions (2015-2020)
2.2.3 PET Radiopharmaceuticals Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global PET Radiopharmaceuticals Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global PET Radiopharmaceuticals Revenue Market Share by Manufacturers (2015-2020)
3.3 Global PET Radiopharmaceuticals Average Price by Manufacturers (2015-2020)
4 PET RADIOPHARMACEUTICALS PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America PET Radiopharmaceuticals Market Size (2015-2026)
4.1.2 PET Radiopharmaceuticals Key Players in North America (2015-2020)
4.1.3 North America PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.1.4 North America PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia PET Radiopharmaceuticals Market Size (2015-2026)
4.2.2 PET Radiopharmaceuticals Key Players in East Asia (2015-2020)
4.2.3 East Asia PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.2.4 East Asia PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe PET Radiopharmaceuticals Market Size (2015-2026)
4.3.2 PET Radiopharmaceuticals Key Players in Europe (2015-2020)
4.3.3 Europe PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.3.4 Europe PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia PET Radiopharmaceuticals Market Size (2015-2026)
4.4.2 PET Radiopharmaceuticals Key Players in South Asia (2015-2020)
4.4.3 South Asia PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.4.4 South Asia PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia PET Radiopharmaceuticals Market Size (2015-2026)
4.5.2 PET Radiopharmaceuticals Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.5.4 Southeast Asia PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East PET Radiopharmaceuticals Market Size (2015-2026)
4.6.2 PET Radiopharmaceuticals Key Players in Middle East (2015-2020)
4.6.3 Middle East PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.6.4 Middle East PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa PET Radiopharmaceuticals Market Size (2015-2026)
4.7.2 PET Radiopharmaceuticals Key Players in Africa (2015-2020)
4.7.3 Africa PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.7.4 Africa PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania PET Radiopharmaceuticals Market Size (2015-2026)
4.8.2 PET Radiopharmaceuticals Key Players in Oceania (2015-2020)
4.8.3 Oceania PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.8.4 Oceania PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America PET Radiopharmaceuticals Market Size (2015-2026)
4.9.2 PET Radiopharmaceuticals Key Players in South America (2015-2020)
4.9.3 South America PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.9.4 South America PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World PET Radiopharmaceuticals Market Size (2015-2026)
4.10.2 PET Radiopharmaceuticals Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.10.4 Rest of the World PET Radiopharmaceuticals Market Size by Application (2015-2020)
5 PET RADIOPHARMACEUTICALS CONSUMPTION BY REGION
5.1 North America
5.1.1 North America PET Radiopharmaceuticals Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia PET Radiopharmaceuticals Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe PET Radiopharmaceuticals Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia PET Radiopharmaceuticals Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia PET Radiopharmaceuticals Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East PET Radiopharmaceuticals Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa PET Radiopharmaceuticals Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania PET Radiopharmaceuticals Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America PET Radiopharmaceuticals Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World PET Radiopharmaceuticals Consumption by Countries
5.10.2 Kazakhstan
6 PET RADIOPHARMACEUTICALS SALES MARKET BY TYPE (2015-2026)
6.1 Global PET Radiopharmaceuticals Historic Market Size by Type (2015-2020)
6.2 Global PET Radiopharmaceuticals Forecasted Market Size by Type (2021-2026)
7 PET RADIOPHARMACEUTICALS CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global PET Radiopharmaceuticals Historic Market Size by Application (2015-2020)
7.2 Global PET Radiopharmaceuticals Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN PET RADIOPHARMACEUTICALS BUSINESS
8.1 Cardinal Health Inc. (U.S.)
8.1.1 Cardinal Health Inc. (U.S.) Company Profile
8.1.2 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Specification
8.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Nordion, Inc. (Canada)
8.2.1 Nordion, Inc. (Canada) Company Profile
8.2.2 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Specification
8.2.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Lantheus Medical Imaging, Inc. (U.S.)
8.3.1 Lantheus Medical Imaging, Inc. (U.S.) Company Profile
8.3.2 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Specification
8.3.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Mallinckrodt plc (Ireland)
8.4.1 Mallinckrodt plc (Ireland) Company Profile
8.4.2 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Specification
8.4.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Eczacibasi-Monrol Nuclear Products (Turkey)
8.5.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Profile
8.5.2 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Specification
8.5.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 GE Healthcare (U.K.)
8.6.1 GE Healthcare (U.K.) Company Profile
8.6.2 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Specification
8.6.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 IBA Molecular Imaging (Belgium)
8.7.1 IBA Molecular Imaging (Belgium) Company Profile
8.7.2 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Specification
8.7.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Bracco Imaging S.p.A (Italy)
8.8.1 Bracco Imaging S.p.A (Italy) Company Profile
8.8.2 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Specification
8.8.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Bayer AG (Germany)
8.9.1 Bayer AG (Germany) Company Profile
8.9.2 Bayer AG (Germany) PET Radiopharmaceuticals Product Specification
8.9.3 Bayer AG (Germany) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Advanced Accelerator Applications S.A. (France)
8.10.1 Advanced Accelerator Applications S.A. (France) Company Profile
8.10.2 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Specification
8.10.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of PET Radiopharmaceuticals (2021-2026)
9.2 Global Forecasted Revenue of PET Radiopharmaceuticals (2021-2026)
9.3 Global Forecasted Price of PET Radiopharmaceuticals (2015-2026)
9.4 Global Forecasted Production of PET Radiopharmaceuticals by Region (2021-2026)
9.4.1 North America PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.2 East Asia PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.3 Europe PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.4 South Asia PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.6 Middle East PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.7 Africa PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.8 Oceania PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.9 South America PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of PET Radiopharmaceuticals by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of PET Radiopharmaceuticals by Country
10.2 East Asia Market Forecasted Consumption of PET Radiopharmaceuticals by Country
10.3 Europe Market Forecasted Consumption of PET Radiopharmaceuticals by Countriy
10.4 South Asia Forecasted Consumption of PET Radiopharmaceuticals by Country
10.5 Southeast Asia Forecasted Consumption of PET Radiopharmaceuticals by Country
10.6 Middle East Forecasted Consumption of PET Radiopharmaceuticals by Country
10.7 Africa Forecasted Consumption of PET Radiopharmaceuticals by Country
10.8 Oceania Forecasted Consumption of PET Radiopharmaceuticals by Country
10.9 South America Forecasted Consumption of PET Radiopharmaceuticals by Country
10.10 Rest of the world Forecasted Consumption of PET Radiopharmaceuticals by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 PET Radiopharmaceuticals Distributors List
11.3 PET Radiopharmaceuticals Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 PET Radiopharmaceuticals Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by PET Radiopharmaceuticals Revenue
1.4 Market Analysis by Type
1.4.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 F-18
1.4.3 Ru-82
1.4.4 Others
1.5 Market by Application
1.5.1 Global PET Radiopharmaceuticals Market Share by Application: 2021-2026
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Neurology
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global PET Radiopharmaceuticals Market Perspective (2021-2026)
2.2 PET Radiopharmaceuticals Growth Trends by Regions
2.2.1 PET Radiopharmaceuticals Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 PET Radiopharmaceuticals Historic Market Size by Regions (2015-2020)
2.2.3 PET Radiopharmaceuticals Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global PET Radiopharmaceuticals Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global PET Radiopharmaceuticals Revenue Market Share by Manufacturers (2015-2020)
3.3 Global PET Radiopharmaceuticals Average Price by Manufacturers (2015-2020)
4 PET RADIOPHARMACEUTICALS PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America PET Radiopharmaceuticals Market Size (2015-2026)
4.1.2 PET Radiopharmaceuticals Key Players in North America (2015-2020)
4.1.3 North America PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.1.4 North America PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia PET Radiopharmaceuticals Market Size (2015-2026)
4.2.2 PET Radiopharmaceuticals Key Players in East Asia (2015-2020)
4.2.3 East Asia PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.2.4 East Asia PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe PET Radiopharmaceuticals Market Size (2015-2026)
4.3.2 PET Radiopharmaceuticals Key Players in Europe (2015-2020)
4.3.3 Europe PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.3.4 Europe PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia PET Radiopharmaceuticals Market Size (2015-2026)
4.4.2 PET Radiopharmaceuticals Key Players in South Asia (2015-2020)
4.4.3 South Asia PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.4.4 South Asia PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia PET Radiopharmaceuticals Market Size (2015-2026)
4.5.2 PET Radiopharmaceuticals Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.5.4 Southeast Asia PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East PET Radiopharmaceuticals Market Size (2015-2026)
4.6.2 PET Radiopharmaceuticals Key Players in Middle East (2015-2020)
4.6.3 Middle East PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.6.4 Middle East PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa PET Radiopharmaceuticals Market Size (2015-2026)
4.7.2 PET Radiopharmaceuticals Key Players in Africa (2015-2020)
4.7.3 Africa PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.7.4 Africa PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania PET Radiopharmaceuticals Market Size (2015-2026)
4.8.2 PET Radiopharmaceuticals Key Players in Oceania (2015-2020)
4.8.3 Oceania PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.8.4 Oceania PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America PET Radiopharmaceuticals Market Size (2015-2026)
4.9.2 PET Radiopharmaceuticals Key Players in South America (2015-2020)
4.9.3 South America PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.9.4 South America PET Radiopharmaceuticals Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World PET Radiopharmaceuticals Market Size (2015-2026)
4.10.2 PET Radiopharmaceuticals Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.10.4 Rest of the World PET Radiopharmaceuticals Market Size by Application (2015-2020)
5 PET RADIOPHARMACEUTICALS CONSUMPTION BY REGION
5.1 North America
5.1.1 North America PET Radiopharmaceuticals Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia PET Radiopharmaceuticals Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe PET Radiopharmaceuticals Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia PET Radiopharmaceuticals Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia PET Radiopharmaceuticals Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East PET Radiopharmaceuticals Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa PET Radiopharmaceuticals Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania PET Radiopharmaceuticals Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America PET Radiopharmaceuticals Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World PET Radiopharmaceuticals Consumption by Countries
5.10.2 Kazakhstan
6 PET RADIOPHARMACEUTICALS SALES MARKET BY TYPE (2015-2026)
6.1 Global PET Radiopharmaceuticals Historic Market Size by Type (2015-2020)
6.2 Global PET Radiopharmaceuticals Forecasted Market Size by Type (2021-2026)
7 PET RADIOPHARMACEUTICALS CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global PET Radiopharmaceuticals Historic Market Size by Application (2015-2020)
7.2 Global PET Radiopharmaceuticals Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN PET RADIOPHARMACEUTICALS BUSINESS
8.1 Cardinal Health Inc. (U.S.)
8.1.1 Cardinal Health Inc. (U.S.) Company Profile
8.1.2 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Specification
8.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Nordion, Inc. (Canada)
8.2.1 Nordion, Inc. (Canada) Company Profile
8.2.2 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Specification
8.2.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Lantheus Medical Imaging, Inc. (U.S.)
8.3.1 Lantheus Medical Imaging, Inc. (U.S.) Company Profile
8.3.2 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Specification
8.3.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Mallinckrodt plc (Ireland)
8.4.1 Mallinckrodt plc (Ireland) Company Profile
8.4.2 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Specification
8.4.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Eczacibasi-Monrol Nuclear Products (Turkey)
8.5.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Profile
8.5.2 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Specification
8.5.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 GE Healthcare (U.K.)
8.6.1 GE Healthcare (U.K.) Company Profile
8.6.2 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Specification
8.6.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 IBA Molecular Imaging (Belgium)
8.7.1 IBA Molecular Imaging (Belgium) Company Profile
8.7.2 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Specification
8.7.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Bracco Imaging S.p.A (Italy)
8.8.1 Bracco Imaging S.p.A (Italy) Company Profile
8.8.2 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Specification
8.8.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Bayer AG (Germany)
8.9.1 Bayer AG (Germany) Company Profile
8.9.2 Bayer AG (Germany) PET Radiopharmaceuticals Product Specification
8.9.3 Bayer AG (Germany) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Advanced Accelerator Applications S.A. (France)
8.10.1 Advanced Accelerator Applications S.A. (France) Company Profile
8.10.2 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Specification
8.10.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of PET Radiopharmaceuticals (2021-2026)
9.2 Global Forecasted Revenue of PET Radiopharmaceuticals (2021-2026)
9.3 Global Forecasted Price of PET Radiopharmaceuticals (2015-2026)
9.4 Global Forecasted Production of PET Radiopharmaceuticals by Region (2021-2026)
9.4.1 North America PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.2 East Asia PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.3 Europe PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.4 South Asia PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.6 Middle East PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.7 Africa PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.8 Oceania PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.9 South America PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of PET Radiopharmaceuticals by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of PET Radiopharmaceuticals by Country
10.2 East Asia Market Forecasted Consumption of PET Radiopharmaceuticals by Country
10.3 Europe Market Forecasted Consumption of PET Radiopharmaceuticals by Countriy
10.4 South Asia Forecasted Consumption of PET Radiopharmaceuticals by Country
10.5 Southeast Asia Forecasted Consumption of PET Radiopharmaceuticals by Country
10.6 Middle East Forecasted Consumption of PET Radiopharmaceuticals by Country
10.7 Africa Forecasted Consumption of PET Radiopharmaceuticals by Country
10.8 Oceania Forecasted Consumption of PET Radiopharmaceuticals by Country
10.9 South America Forecasted Consumption of PET Radiopharmaceuticals by Country
10.10 Rest of the world Forecasted Consumption of PET Radiopharmaceuticals by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 PET Radiopharmaceuticals Distributors List
11.3 PET Radiopharmaceuticals Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 PET Radiopharmaceuticals Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
LIST OF TABLES AND FIGURES
Table 1. Global PET Radiopharmaceuticals Market Share by Type: 2020 VS 2026
Table 2. F-18 Features
Table 3. Ru-82 Features
Table 4. Others Features
Table 11. Global PET Radiopharmaceuticals Market Share by Application: 2020 VS 2026
Table 12. Oncology Case Studies
Table 13. Cardiology Case Studies
Table 14. Neurology Case Studies
Table 15. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. PET Radiopharmaceuticals Report Years Considered
Table 29. Global PET Radiopharmaceuticals Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global PET Radiopharmaceuticals Market Share by Regions: 2021 VS 2026
Table 31. North America PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 42. East Asia PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 43. Europe PET Radiopharmaceuticals Consumption by Region (2015-2020)
Table 44. South Asia PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 45. Southeast Asia PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 46. Middle East PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 47. Africa PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 48. Oceania PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 49. South America PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 50. Rest of the World PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 51. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Specification
Table 52. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Specification
Table 53. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Specification
Table 54. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Specification
Table 55. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Specification
Table 56. GE Healthcare (U.K.) PET Radiopharmaceuticals Product Specification
Table 57. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Specification
Table 58. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Specification
Table 59. Bayer AG (Germany) PET Radiopharmaceuticals Product Specification
Table 60. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Specification
Table 101. Global PET Radiopharmaceuticals Production Forecast by Region (2021-2026)
Table 102. Global PET Radiopharmaceuticals Sales Volume Forecast by Type (2021-2026)
Table 103. Global PET Radiopharmaceuticals Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global PET Radiopharmaceuticals Sales Revenue Forecast by Type (2021-2026)
Table 105. Global PET Radiopharmaceuticals Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global PET Radiopharmaceuticals Sales Price Forecast by Type (2021-2026)
Table 107. Global PET Radiopharmaceuticals Consumption Volume Forecast by Application (2021-2026)
Table 108. Global PET Radiopharmaceuticals Consumption Value Forecast by Application (2021-2026)
Table 109. North America PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 110. East Asia PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 111. Europe PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 112. South Asia PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 114. Middle East PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 115. Africa PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 116. Oceania PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 117. South America PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 119. PET Radiopharmaceuticals Distributors List
Table 120. PET Radiopharmaceuticals Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 2. North America PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 3. United States PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 4. Canada PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 5. Mexico PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 6. East Asia PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 7. East Asia PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 8. China PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 9. Japan PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 10. South Korea PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 11. Europe PET Radiopharmaceuticals Consumption and Growth Rate
Figure 12. Europe PET Radiopharmaceuticals Consumption Market Share by Region in 2020
Figure 13. Germany PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 15. France PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 16. Italy PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 17. Russia PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 18. Spain PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 21. Poland PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 22. South Asia PET Radiopharmaceuticals Consumption and Growth Rate
Figure 23. South Asia PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 24. India PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia PET Radiopharmaceuticals Consumption and Growth Rate
Figure 28. Southeast Asia PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 29. Indonesia PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 30. Thailand PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 31. Singapore PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 33. Philippines PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 36. Middle East PET Radiopharmaceuticals Consumption and Growth Rate
Figure 37. Middle East PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 38. Turkey PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 40. Iran PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 42. Israel PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 43. Iraq PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 44. Qatar PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 46. Oman PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 47. Africa PET Radiopharmaceuticals Consumption and Growth Rate
Figure 48. Africa PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 49. Nigeria PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 50. South Africa PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 51. Egypt PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 52. Algeria PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 53. Morocco PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 54. Oceania PET Radiopharmaceuticals Consumption and Growth Rate
Figure 55. Oceania PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 56. Australia PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 58. South America PET Radiopharmaceuticals Consumption and Growth Rate
Figure 59. South America PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 60. Brazil PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 61. Argentina PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 62. Columbia PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 63. Chile PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 65. Peru PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World PET Radiopharmaceuticals Consumption and Growth Rate
Figure 69. Rest of the World PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 71. Global PET Radiopharmaceuticals Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global PET Radiopharmaceuticals Price and Trend Forecast (2015-2026)
Figure 74. North America PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 75. North America PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 79. Europe PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 87. Africa PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 91. South America PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 95. East Asia PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 96. Europe PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 97. South Asia PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 98. Southeast Asia PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 99. Middle East PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 100. Africa PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 101. Oceania PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 102. South America PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 103. Rest of the world PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Table 1. Global PET Radiopharmaceuticals Market Share by Type: 2020 VS 2026
Table 2. F-18 Features
Table 3. Ru-82 Features
Table 4. Others Features
Table 11. Global PET Radiopharmaceuticals Market Share by Application: 2020 VS 2026
Table 12. Oncology Case Studies
Table 13. Cardiology Case Studies
Table 14. Neurology Case Studies
Table 15. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. PET Radiopharmaceuticals Report Years Considered
Table 29. Global PET Radiopharmaceuticals Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global PET Radiopharmaceuticals Market Share by Regions: 2021 VS 2026
Table 31. North America PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World PET Radiopharmaceuticals Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 42. East Asia PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 43. Europe PET Radiopharmaceuticals Consumption by Region (2015-2020)
Table 44. South Asia PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 45. Southeast Asia PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 46. Middle East PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 47. Africa PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 48. Oceania PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 49. South America PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 50. Rest of the World PET Radiopharmaceuticals Consumption by Countries (2015-2020)
Table 51. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Specification
Table 52. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Specification
Table 53. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Specification
Table 54. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Specification
Table 55. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Specification
Table 56. GE Healthcare (U.K.) PET Radiopharmaceuticals Product Specification
Table 57. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Specification
Table 58. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Specification
Table 59. Bayer AG (Germany) PET Radiopharmaceuticals Product Specification
Table 60. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Specification
Table 101. Global PET Radiopharmaceuticals Production Forecast by Region (2021-2026)
Table 102. Global PET Radiopharmaceuticals Sales Volume Forecast by Type (2021-2026)
Table 103. Global PET Radiopharmaceuticals Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global PET Radiopharmaceuticals Sales Revenue Forecast by Type (2021-2026)
Table 105. Global PET Radiopharmaceuticals Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global PET Radiopharmaceuticals Sales Price Forecast by Type (2021-2026)
Table 107. Global PET Radiopharmaceuticals Consumption Volume Forecast by Application (2021-2026)
Table 108. Global PET Radiopharmaceuticals Consumption Value Forecast by Application (2021-2026)
Table 109. North America PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 110. East Asia PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 111. Europe PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 112. South Asia PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 114. Middle East PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 115. Africa PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 116. Oceania PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 117. South America PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world PET Radiopharmaceuticals Consumption Forecast 2021-2026 by Country
Table 119. PET Radiopharmaceuticals Distributors List
Table 120. PET Radiopharmaceuticals Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 2. North America PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 3. United States PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 4. Canada PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 5. Mexico PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 6. East Asia PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 7. East Asia PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 8. China PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 9. Japan PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 10. South Korea PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 11. Europe PET Radiopharmaceuticals Consumption and Growth Rate
Figure 12. Europe PET Radiopharmaceuticals Consumption Market Share by Region in 2020
Figure 13. Germany PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 15. France PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 16. Italy PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 17. Russia PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 18. Spain PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 21. Poland PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 22. South Asia PET Radiopharmaceuticals Consumption and Growth Rate
Figure 23. South Asia PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 24. India PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia PET Radiopharmaceuticals Consumption and Growth Rate
Figure 28. Southeast Asia PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 29. Indonesia PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 30. Thailand PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 31. Singapore PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 33. Philippines PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 36. Middle East PET Radiopharmaceuticals Consumption and Growth Rate
Figure 37. Middle East PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 38. Turkey PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 40. Iran PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 42. Israel PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 43. Iraq PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 44. Qatar PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 46. Oman PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 47. Africa PET Radiopharmaceuticals Consumption and Growth Rate
Figure 48. Africa PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 49. Nigeria PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 50. South Africa PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 51. Egypt PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 52. Algeria PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 53. Morocco PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 54. Oceania PET Radiopharmaceuticals Consumption and Growth Rate
Figure 55. Oceania PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 56. Australia PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 58. South America PET Radiopharmaceuticals Consumption and Growth Rate
Figure 59. South America PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 60. Brazil PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 61. Argentina PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 62. Columbia PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 63. Chile PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 65. Peru PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World PET Radiopharmaceuticals Consumption and Growth Rate
Figure 69. Rest of the World PET Radiopharmaceuticals Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan PET Radiopharmaceuticals Consumption and Growth Rate (2015-2020)
Figure 71. Global PET Radiopharmaceuticals Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global PET Radiopharmaceuticals Price and Trend Forecast (2015-2026)
Figure 74. North America PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 75. North America PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 79. Europe PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 87. Africa PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 91. South America PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World PET Radiopharmaceuticals Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World PET Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 95. East Asia PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 96. Europe PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 97. South Asia PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 98. Southeast Asia PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 99. Middle East PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 100. Africa PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 101. Oceania PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 102. South America PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 103. Rest of the world PET Radiopharmaceuticals Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
